marketcap
Facebook
Twitter
Telegram
Report an ErrorQuarterly report 2024-Q3
added 11-12-2024
Atossa Therapeutics Cash Flow 2011-2024 | ATOS
Annual Cash Flow Atossa Therapeutics
| 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 | 2013 | 2012 | 2011 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Operating Cash Flow |
-20.9 M | -20.8 M | -16.5 M | -11.6 M | -9.13 M | -8.96 M | -6.59 M | -5.37 M | -14 M | -10.6 M | - | -3.9 M | -3.49 M |
Depreciation & Amortization |
23 K | 8 K | 23 K | 47 K | 52.8 K | 44.2 K | 129 K | 303 K | 273 K | 480 K | 473 K | 131 K | 15.6 K |
Accounts Payables |
806 K | 2.96 M | 1.72 M | 1.59 M | 293 K | 353 K | 335 K | 254 K | 814 K | 594 K | 9.63 K | 68.2 K | - |
Accounts Receivables |
- | - | - | - | - | - | - | - | - | 298 K | 139 K | 142 K | - |
Total Inventories |
- | - | - | - | - | - | - | - | - | 39.8 K | - | - | - |
All numbers in USD currency
Quarterly Cash Flow Atossa Therapeutics
| 2024-Q3 | 2024-Q2 | 2024-Q1 | 2023-Q4 | 2023-Q3 | 2023-Q2 | 2023-Q1 | 2022-Q4 | 2022-Q3 | 2022-Q2 | 2022-Q1 | 2021-Q4 | 2021-Q3 | 2021-Q2 | 2021-Q1 | 2020-Q4 | 2020-Q3 | 2020-Q2 | 2020-Q1 | 2019-Q4 | 2019-Q3 | 2019-Q2 | 2019-Q1 | 2018-Q4 | 2018-Q3 | 2018-Q2 | 2018-Q1 | 2017-Q4 | 2017-Q3 | 2017-Q2 | 2017-Q1 | 2016-Q4 | 2016-Q3 | 2016-Q2 | 2016-Q1 | 2015-Q4 | 2015-Q3 | 2015-Q2 | 2015-Q1 | 2014-Q4 | 2014-Q3 | 2014-Q2 | 2014-Q1 | 2013-Q4 | 2013-Q3 | 2013-Q2 | 2013-Q1 | 2012-Q4 | 2012-Q3 | 2012-Q2 | 2012-Q1 | 2011-Q4 | 2011-Q3 | 2011-Q2 | 2011-Q1 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Operating Cash Flow |
- | - | -4.7 M | - | - | - | -7.02 M | - | -16.2 M | -10.8 M | -4.88 M | - | -12.8 M | -9.74 M | -4.41 M | - | -8.14 M | -5.46 M | -3.23 M | - | -6.42 M | -4.65 M | -2.15 M | - | -6.52 M | -4.22 M | -2.39 M | - | -4.91 M | -3.21 M | -6.6 M | - | -4.02 M | - | -2.99 M | - | -10 M | -6.52 M | -3 M | - | - | - | - | - | - | - | -1.33 M | - | -1.97 M | -1.82 M | -1.01 M | - | -2.45 M | - | - |
Depreciation & Amortization |
- | - | 5 K | - | - | - | 3 K | - | 6 K | 4 K | 2 K | - | 21 K | 15 K | 9 K | - | 37.3 K | 24.7 K | 12.3 K | - | 40.3 K | 27.5 K | 14 K | - | 28.7 K | 17.8 K | 7.86 K | - | 102 K | 73.2 K | 40.1 K | - | 227 K | 153 K | 75.7 K | - | 168 K | 55.3 K | 64.2 K | - | 381 K | 253 K | 125 K | - | 351 K | 227 K | 98.9 K | - | 25.6 K | 17.1 K | 8.53 K | - | 6.42 K | - | - |
Accounts Payables |
1.56 M | 1.06 M | 1.23 M | 806 K | 718 K | 1.17 M | 1.44 M | 2.96 M | 1.65 M | 2.05 M | 1.6 M | 1.72 M | 668 K | 538 K | 722 K | 1.59 M | 1.59 M | 1.59 M | 1.59 M | 293 K | 293 K | 293 K | 293 K | 353 K | 353 K | 353 K | 353 K | 335 K | 335 K | 335 K | 335 K | 254 K | 254 K | 254 K | 254 K | 814 K | 814 K | 814 K | 814 K | 513 K | 594 K | 594 K | 594 K | 248 K | 248 K | 248 K | 9.63 K | 68.2 K | 68.2 K | 68.2 K | 68.2 K | 64.8 K | 64.8 K | - | - |
Accounts Receivables |
- | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | 4.04 K | 2.74 K | - | - | - | - | - | - | 1.06 M | 2.01 M | 1.28 M | 298 K | 29.2 K | 298 K | 298 K | 139 K | 139 K | 139 K | 139 K | 142 K | 142 K | 142 K | 142 K | 1.22 K | 1.22 K | - | - |
Total Inventories |
- | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | 171 K | 101 K | 94.6 K | 9.28 K | 39.8 K | 39.8 K | 39.8 K | - | - | - | - | - | - | - | - | - | - | - | - |
All numbers in USD currency